Oleg Nodelman
Directeur/Bestuurslid bij PROTHENA CORPORATION PLC
Oorsprong van het eerstegraads netwerk van Oleg Nodelman
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Georgetown University
497
| College/University | Other Consumer Services | 497 |
| Public Company | Biotechnology | 24 | |
| Public Company | Biotechnology | 22 | |
| Public Company | Pharmaceuticals: Major | 12 | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA.
9
| Holding Company | Pharmaceuticals: Major | 9 |
| Private Company | Financial Conglomerates | 8 | |
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients.
7
| Private Company | Investment Managers | 7 |
| Public Company | Biotechnology | 7 | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020.
7
| Holding Company | Medical/Nursing Services | 7 |
Panacea Acquisition Corp.
 Panacea Acquisition Corp. Financial ConglomeratesFinance Panacea Acquisition Corp. is a blank check company with the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in April 2020 and is headquartered in San Francisco, CA.
6
| Extinct | Financial Conglomerates | 6 |
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat.
6
| Holding Company | Biotechnology | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Oleg Nodelman via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Cambridge | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | General Counsel Director/Board Member Director/Board Member Corporate Officer/Principal | |
| AFFYMAX, INC. | Biotechnology | Chairman Corporate Officer/Principal Chief Executive Officer Comptroller/Controller/Auditor | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of San Diego | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Founder | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| AFFYMETRIX, INC. | Medical Specialties | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer | |
| TRANSLATE BIO, INC. | Biotechnology | Founder Director/Board Member Corporate Officer/Principal | |
| University of Oxford | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member | |
| CELGENE | Biotechnology | Corporate Officer/Principal President Director/Board Member | |
| University of Michigan | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TURMERIC ACQUISITION CORP. | Financial Conglomerates | Director of Finance/CFO President Chairman | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Public Communications Contact Corporate Officer/Principal | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Founder | |
Protego Biopharma, Inc.
 Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Protego Biopharma operates as a biotechnology firm. The company is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| New York University | College/University | Undergraduate Degree Masters Business Admin | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rempex Pharmaceuticals, Inc. develops new therapies to combat the growing issue of antibiotic resistance. It focuses on the discovery and development of new antibacterial drugs to meet the clinical need created by multi-drug resistant bacterial pathogens. The company was founded by Daniel Burgess, Michael Dudley and Jeffery Loutit in June 2011 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Founder Director/Board Member | |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Biotechnology | Director/Board Member Founder | |
| Berkeley Law University of California | College/University | Graduate Degree Graduate Degree | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Chief Executive Officer Director/Board Member | |
| Amherst College | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of North Carolina at Charlotte | College/University | Masters Business Admin Undergraduate Degree | |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member Chief Tech/Sci/R&D Officer | |
Affini-T Therapeutics, Inc.
 Affini-T Therapeutics, Inc. BiotechnologyHealth Technology Affini-T Therapeutics, Inc. is a biotechnology company based in Watertown, MA. Affini-t is focused on developing potentially curative therapies for solid tumor cancers by unlocking the power of T cells and targeting core oncogenic drivers. The company's differentiated cell therapy platform harnesses state-of-the-art engineering and synthetic biology capabilities to optimize T cell functions and rewrite the rules of the solid tumor microenvironment, enabling the potential for sustained clinical outcomes in patients. The company is targeting Kras and other oncogenic and viral driver mutations to open a new and differentiated target space, thereby minimizing the risk of cancer. The company was founded by Jak Knowles and Arjun Goyal, with Jak Knowles serving as the CEO since incorporation. | Biotechnology | Founder Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Verenigd Koninkrijk | 4 |
| Ierland | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 14 |
| Finance | 6 |
| Commercial Services | 4 |
Operationeel
| Director/Board Member | 699 |
| Corporate Officer/Principal | 230 |
| Independent Dir/Board Member | 196 |
| Chairman | 91 |
| Undergraduate Degree | 89 |
Sterkste connecties
| Insiders | |
|---|---|
| James Topper | 52 |
| Amir Nashat | 51 |
| Nina Kjellson | 49 |
| Jean-Francois Formela | 48 |
| Peter Thompson | 39 |
| Todd Foley | 38 |
| Otello Stampacchia | 37 |
| Timothy Haines | 36 |
| Helen Kim | 34 |
| Shelley Chu | 31 |
| Magda Marquet | 30 |
| Alan Colowick | 30 |
| Dennis Fenton | 28 |
| Edward Hurwitz | 27 |
| Douglas Williams | 25 |
- Beurs
- Insiders
- Oleg Nodelman
- Bedrijfsconnecties
